These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7287668)

  • 1. Quantitative determination of individual non-sulfated bile acids and sulfated lithocholic acid in serum by mass fragmentography.
    Beppu T; Seyama Y; Kasama T; Yamakawa T
    J Biochem; 1981 Jun; 89(6):1963-73. PubMed ID: 7287668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of bile acid glucuronides in serum by mass fragmentography.
    Takikawa H; Otsuka H; Beppu T; Seyama Y; Yamakawa T
    J Biochem; 1982 Oct; 92(4):985-98. PubMed ID: 7174649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum bile acids in normal human subjects following the adoption of a low-fat diet.
    Martucci CP; Miller DG; Levine B; Tint GS; Fishman J
    Ann N Y Acad Sci; 1995 Sep; 768():331-3. PubMed ID: 8526380
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of lithocholic acid and measurement of other bile acids in serum of healthy humans.
    Pellizzari ED; O'Neil FS; Farmer RW; Fabre LF
    Clin Chem; 1973 Feb; 19(2):248-52. PubMed ID: 4346071
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence of daily stability of fasting serum bile acid levels in healthy volunteers].
    Stepani P; Iglicki F; Guerhardt MF; Myara A; Capron JP
    Gastroenterol Clin Biol; 2000 May; 24(5):594-5. PubMed ID: 10891758
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum bile acid profiles in cerebrotendinous xanthomatosis.
    Beppu T; Seyama Y; Kasama T; Serizawa S; Yamakawa T
    Clin Chim Acta; 1982 Feb; 118(2-3):167-75. PubMed ID: 7055978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of bile acid glucuronides in hepatobiliary diseases.
    Takikawa H; Otsuka H; Beppu T; Seyama Y; Yamakawa T
    Digestion; 1983; 27(4):189-95. PubMed ID: 6653918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography.
    Murata N; Beppu T; Takikawa H; Otsuka H; Kasama T; Seyama Y
    Steroids; 1983 Nov; 42(5):575-92. PubMed ID: 6101264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified procedure for the isolation of bile acids from serum based on a batch extraction with the non-ionic resin--Amberlite XAD-7.
    Barnes S; Chitranukroh A
    Ann Clin Biochem; 1977 Jul; 14(4):235-9. PubMed ID: 900857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
    Poupon RE; Chrétien Y; Poupon R; Paumgartner G
    Hepatology; 1993 Apr; 17(4):599-604. PubMed ID: 8477964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size.
    Angelin B; Bjökhem I; Einarsson K
    J Lipid Res; 1978 Jul; 19(5):527-37. PubMed ID: 670831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis.
    Campbell CB; McGuffie C; Powell LW; Roberts RK; Stewart AW
    Am J Dig Dis; 1978 Jul; 23(7):599-608. PubMed ID: 685925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W; Schreiber J; Walczak M
    Z Gastroenterol; 1973 May; 11(4):279-88. PubMed ID: 4803425
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bile acid analysis.
    Setchell KD; Matsui A
    Clin Chim Acta; 1983 Jan; 127(1):1-17. PubMed ID: 6337748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bile acid profile in thyroid dysfunction and effect of medical treatment.
    Kosuge T; Beppu T; Kodama T; Hidai K; Idezuki Y
    Clin Sci (Lond); 1987 Oct; 73(4):425-9. PubMed ID: 3665361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
    Stiehl A; Earnest DL; Admirant WH
    Gastroenterology; 1975 Mar; 68(3):534-44. PubMed ID: 1112455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
    J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.